If You Have $1,000 to Invest Today, Should It Go Into SpaceX or the S&P 500? History Has a Clear Answer.

SpaceX’s post-IPO momentum is highlighted as potentially short-lived, with the article citing historical data showing companies with a float below 10% and over $100 million in revenue generated average market-adjusted returns of -5.3% in the three years after IPO. The piece argues the S&P 500 is the lower-risk choice for investors, while noting SpaceX could face selling pressure once insider lockups expire and more shares enter the market. It also expects the S&P 500 to eventually include SpaceX, likely in mid- to late-2027, assuming continued trading and profitability.

Analysis

The market is likely mispricing the post-IPO supply overhang as a one-way negative for the newly listed name, but the more important second-order effect is on passive ownership and index flows. Once eligibility is achieved, inclusion into broad benchmarks can create a persistent bid that absorbs retail/insider distribution; that tends to compress volatility but also caps upside as the easy scarcity premium disappears. In other words, the trade may transition from a scarcity squeeze to a flow-sensitive utility-like equity faster than momentum traders expect.

The real setup is not “buy the IPO or buy the index,” but a regime shift in who is forced to own the name. Early holders are buying optionality on future dominance, while index funds will eventually own a diluted, mature version of that optionality with less valuation convexity. That usually favors selling strength after initial lock-up/eligibility milestones and waiting for the inevitable post-hype drawdown to establish exposure, rather than chasing the first-leg move.

The contrarian mistake is assuming high-revenue, low-float IPOs always mean secular winners; historically, these deals often underperform once the float expands because the marginal seller is more informed than the marginal buyer. The catalyst that could break that pattern is if profitability and a clean path to inclusion arrive sooner than expected, pulling in benchmark demand before insider supply fully clears. But absent a hard fundamental surprise, the shorter the time horizon, the more the name behaves like a sentiment instrument rather than a compounding asset.

For the broader market, the eventual inclusion into passive portfolios is incrementally supportive for large-cap index products, but the effect is likely too small to change S&P positioning materially. The bigger edge is in dispersion: crowded demand for the high-profile IPO can temporarily siphon capital from quality growth names, creating relative-value opportunities in established mega-cap compounders that already have proven free-cash-flow durability.

Key Decisions for Investors

• Fade the post-IPO momentum: look to short or sell into strength in the new listing over the next 1-3 months, especially into any lock-up-related supply events; target a mean reversion trade with tight risk controls because the setup is more flow-driven than fundamental.
• Prefer buying the S&P 500 ETF on any pullback rather than chasing the IPO; the index offers exposure to the eventual inclusion with materially lower idiosyncratic risk and a better downside profile over the next 6-12 months.
• If you want upside with less binary risk, pair long NVDA against the IPO over a 3-6 month horizon: NVDA has proven monetization and cash conversion, while the new listing still faces post-hype multiple compression and supply overhang.
• Consider a small tactical call spread only if the stock re-tests post-IPO support after the first distribution wave; use defined risk because upside is front-loaded while downside can accelerate once insider selling begins.
• Monitor benchmark-eligibility and profitability milestones as catalysts; if inclusion timing pulls forward, cover shorts and rotate to a neutral stance because passive demand can quickly overwhelm bearish supply assumptions.